As a senior brand manager at GSK Consumer Healthcare India, he will lead the strategy, execution, and growth of Eno.

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

Haleon has gained full control of its Chinese joint venture after acquiring Tianjin Pharmaceutical Da Ren Tang's 12% stake.

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

This is not a solicitation from a lawyer. PHILADELPHIA, April 11, 2025 /PRNewswire/ -- Defendants GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (now known as Haleon US Holdings LLC ...

GlaxoSmithKline is understood to be the sole bidder for Pfizer’s $15-20bn consumer health unit after Reckitt Benckiser pulled out. Reckitt’s shares jumped after it published a short statement ...

The company was formerly known as GlaxoSmithKline and is a multinational biopharmaceutical and healthcare company that creates and markets a variety of consumer health products, drugs, and vaccines.

Centrum, a trusted name in comprehensive multivitamin support, today announced the expansion of its product portfolio with the launch of Centrum Recharge, a new entrant into the competitive Energy ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

Dr. Kiran Mahasuar, Asst Professor at IMT Ghaziabad, writes why branded generics may still dominate volumes, but the real ...